Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole Ointment in Asian Patients With Mild to Moderate Atopic Dermatitis
CTR20200843Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of crisaborole in atopic dermatitis (AD), sponsored by Pfizer. Started Oct 2020; status: completed.
02
Drugs
crisaborole
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20200843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200843.